🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMy fatty liver reversal — November 2025 Page 5

My fatty liver reversal — November 2025

rachel_ABQ Mon, Dec 15, 2025 at 11:22 AM 33 replies 1,345 viewsPage 5 of 7
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Dec 22, 2025 at 6:47 AM#21
Dr.NutriCornell said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

There is a second half to this that has not been said yet. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

29 2wanda_boise, NurseAsh_DET, BenResearch_OR and 26 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Dec 22, 2025 at 9:27 PM#22

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Last edited: Dec 22, 2025 at 10:27 PM
30 3DoseLogDan, SleepFixSam, PurityPaulOR and 27 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Dec 23, 2025 at 12:07 PM#23

One thing that is still open after Dr.NutriCornell’s answer:

How would you tell the difference between that and the alternative explanation?

31 4PharmHunterJen, TomTeleRx, DoseLogDan and 28 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Dec 24, 2025 at 2:46 AM#24
raj_cambridge said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

Last edited: Dec 24, 2025 at 8:46 AM
32 5jim_asheville, matt_MKE, Dr.ReproEndo and 29 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Dec 24, 2025 at 5:25 PM#25
raj_cambridge said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

33 6amy_econ_NJ, bbq_ray_KC, oliver_london and 30 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register